Inno Med
Latest round
- Angel
Last raised
- Jul 2017
Total raised
- Undisclosed
Investors
- 2
About Inno Med
Established in 2016 and based in Shanghai, China, Inno Med is a medical device developer dedicated to providing minimally invasive surgical instruments. The company mainly provides medical device. It provides minimally invasive surgical instruments in the fields of thoracic surgery, neurosurgery, general surgery, etc. Products include micro tumour removal forceps, curved electrocoagulation hooks, double-jointed small snake head forceps, etc. The company generates revenue by providing medical device such as micro tumour removal forceps and curved electrocoagulation hooks.
Who invested in Inno Med
2 investors across 1 round
See all investors in Inno Med
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jul 4, 2017
Amount
Undisclosed
Investors
Questions about Inno Med
Who invested in Inno Med?
Inno Med has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inno Med raised?
Inno Med has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inno Med last raise money?
Inno Med's most recent round on record is a Angel, in Jul 2017.
What does Inno Med do?
Established in 2016 and based in Shanghai, China, Inno Med is a medical device developer dedicated to providing minimally invasive surgical instruments.
Where is Inno Med headquartered?
Inno Med is headquartered in Shanghai, China.
Which VCs invest in companies like Inno Med?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at Inno Med's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Angel
Raising like Inno Med? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.